Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Patti F, Brescia Morra V, Amato M P, Trojano M, Bastianello S, Tola M R, Cottone S, Plant A, Picconi O, COGIMUS Study Group
PLoS One. 2013; 8(8):e74111. Epub 2013 Aug 30. PMID: 24137499.Abstract